Evidence map›Paper›PMID 39239537›Full record

ArticleInternational journal of medical sciences2024

Investigation of cardiorenal outcomes and incidence of genitourinary tract infection after combined SGLT2 inhibitor and ACEI/ARB use in patients with chronic kidney disease stages 3-5: A real-world retrospective cohort study in Taiwan.

Yu-Hsuan Joni Shao, Wan-Ting Chen, Samuel Mon-Wei Yu, Liam Li-An Tsou, Yung-Ho Hsu, Mai-Szu Wu, Yung-Hsi Kao, Chu-Lin Chou, Po-Jen Hsiao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yu-Hsuan Joni ShaoGraduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Wan-Ting ChenHealth and Clinical Research Data Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan.
Samuel Mon-Wei YuDivision of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Liam Li-An TsouDivision of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Yung-Ho HsuTaipei Medical University-Research Center of Urology and Kidney, Taipei Medical University, Taipei, Taiwan.
Mai-Szu WuTaipei Medical University-Research Center of Urology and Kidney, Taipei Medical University, Taipei, Taiwan.
Yung-Hsi KaoDepartment of Life Sciences, National Central University, Taoyuan, Taiwan.
Chu-Lin ChouTaipei Medical University-Research Center of Urology and Kidney, Taipei Medical University, Taipei, Taiwan.
Po-Jen HsiaoDepartment of Life Sciences, National Central University, Taoyuan, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsRenal Insufficiency, ChronicSodium-Glucose Transporter 2 InhibitorsAgedDiabetes Mellitus, Type 2FemaleHumansIncidenceMaleMiddle AgedRetrospective StudiesTaiwanAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsSodium-Glucose Transporter 2 Inhibitorsacute kidney diseaseacute kidney injuryangiotensin-converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB)cardiorenal outcomechronic kidney diseaseend-stage renal diseasegenitourinary tract infectionsodium‒glucose cotransporter-2 (SGLT2) inhibitor

Identifiers

PMID39239537
PMCPMC11373557

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.